Literature DB >> 28993504

Precision Transplant Medicine: Biomarkers to the Rescue.

Maarten Naesens1,2, Dany Anglicheau3,4,5,6,7.   

Abstract

The concept that individuals with the same disease and a similar clinical presentation may have very different outcomes and need very different therapies is not novel. With the development of many innovative tools derived from the omics technologies, transplant medicine is slowly entering the era of precision medicine. Biomarkers are the cornerstone of precision medicine, which aims to integrate biomarkers with traditional clinical information and tailor medical care to achieve the best outcome for an individual patient. Here, we discuss the basic concepts of precision medicine and biomarkers, with a specific focus on progress in renal transplantation. We delineate the different types of biomarkers and provide a general assessment of the current applications and shortcomings of previously proposed biomarkers. We also outline the potential of precision medicine in transplantation. Moving toward precision medicine in the field of transplantation will require transplant physicians to embrace the increased complexity and expanded decision algorithms and therapeutic options that are associated with improved disease nosology.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  acute rejection; chronic allograft failure; chronic graft deterioration; kidney transplantation; transplant outcomes

Mesh:

Substances:

Year:  2017        PMID: 28993504      PMCID: PMC5748900          DOI: 10.1681/ASN.2017010004

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

Review 1.  The elephant in the room: failings of current clinical endpoints in kidney transplantation.

Authors:  J D Schold; B Kaplan
Journal:  Am J Transplant       Date:  2010-05       Impact factor: 8.086

Review 2.  Calcineurin inhibitor nephrotoxicity.

Authors:  Maarten Naesens; Dirk R J Kuypers; Minnie Sarwal
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

Review 3.  Urinary biomarkers of renal transplant outcome.

Authors:  Julie Ho; David N Rush; Peter W Nickerson
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 4.  Management of polyomavirus-associated nephropathy in renal transplant recipients.

Authors:  Dirk R J Kuypers
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

5.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

6.  The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens.

Authors:  Marlies K A Dankers; Marian D Witvliet; Dave L Roelen; Peter de Lange; Nelleke Korfage; Guido G Persijn; René Duquesnoy; Ilias I N Doxiadis; Frans H J Claas
Journal:  Transplantation       Date:  2004-04-27       Impact factor: 4.939

Review 7.  Strategic Use of Epitope Matching to Improve Outcomes.

Authors:  Chris Wiebe; Peter Nickerson
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

8.  Complement-binding anti-HLA antibodies and kidney-allograft survival.

Authors:  Alexandre Loupy; Carmen Lefaucheur; Dewi Vernerey; Christof Prugger; Jean-Paul Duong van Huyen; Nuala Mooney; Caroline Suberbielle; Véronique Frémeaux-Bacchi; Arnaud Méjean; François Desgrandchamps; Dany Anglicheau; Dominique Nochy; Dominique Charron; Jean-Philippe Empana; Michel Delahousse; Christophe Legendre; Denis Glotz; Gary S Hill; Adriana Zeevi; Xavier Jouven
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

9.  Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors:  M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

Review 10.  Urinary MicroRNA as Biomarker in Renal Transplantation.

Authors:  M van de Vrie; J K Deegens; M Eikmans; J van der Vlag; L B Hilbrands
Journal:  Am J Transplant       Date:  2016-11-10       Impact factor: 8.086

View more
  23 in total

1.  Evaluation and Treatment of Acute Rejection in Kidney Allografts.

Authors:  James E Cooper
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-17       Impact factor: 8.237

Review 2.  The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft.

Authors:  Paul Luchian Aldea; Andreea Liana Rachisan; Bogdan Ioan Stanciu; Andrei Picos; Alina Monica Picos; Dan Ioan Delean; Ramona Stroescu; Magdalena Iuliana Starcea; Cristina Maria Borzan; Florin Ioan Elec
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

3.  Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation.

Authors:  Nora Jahn; Maria Theresa Voelker; Sven Laudi; Sebastian Stehr; Stefan Schneeberger; Gerald Brandacher; Elisabeth Sucher; Sebastian Rademacher; Daniel Seehofer; Robert Sucher; Hans Michael Hau
Journal:  J Clin Med       Date:  2022-05-03       Impact factor: 4.964

4.  The Systemic Immune-Inflammation Index Predicts Clinical Outcomes in Kidney Transplant Recipients.

Authors:  Samantha E Halpern; Dimitrios Moris; Brian I Shaw; Madison K Krischak; Danae G Olaso; Samuel J Kesseli; Kadiyala Ravindra; Lisa M McElroy; Andrew S Barbas
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 5.  Chronic Allograft Injury.

Authors:  Eric Langewisch; Roslyn B Mannon
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-05       Impact factor: 8.237

Review 6.  Osteopontin and Transplantation: Where Are We Now?

Authors:  Beata Kaleta
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-05-21       Impact factor: 4.291

7.  A composite of urinary biomarkers for differentiating between tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy in kidney allografts.

Authors:  Yu-Mee Wee; Hae-Won Lee; Monica Young Choi; Hey Rim Jung; Ji Yoon Choi; Hyun Wook Kwon; Joo Hee Jung; Young Hoon Kim; Duck Jong Han; Sung Shin
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-11-27

8.  Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.

Authors:  Fleur S Peters; Annemiek M A Peeters; Pooja R Mandaviya; Joyce B J van Meurs; Leo J Hofland; Jacqueline van de Wetering; Michiel G H Betjes; Carla C Baan; Karin Boer
Journal:  Clin Epigenetics       Date:  2018-06-18       Impact factor: 6.551

9.  A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring.

Authors:  Tara K Sigdel; Joshua Y C Yang; Oriol Bestard; Andrew Schroeder; Szu-Chuan Hsieh; Juliane M Liberto; Izabella Damm; Anna C M Geraedts; Minnie M Sarwal
Journal:  PLoS One       Date:  2019-07-31       Impact factor: 3.240

Review 10.  Precision medicine approaches for diabetic kidney disease: opportunities and challenges.

Authors:  Sok Cin Tye; Petra Denig; Hiddo J L Heerspink
Journal:  Nephrol Dial Transplant       Date:  2021-06-22       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.